Welcome to PsychU!

Psychoneuroimmunology: Mood Disorders Part 2 In PNI Series

Drs. Rachel Self, Carolyn Tyler, and Heather Davidson provide an understanding of the immune system and neuroinflammation and their impact …

You must be logged-in to view this content.

Psychoneuroimmunology: Immune System & Neuroinflammation Basics Part 1 In PNI Series

In a three-part series for PsychU, Drs. Rachel Self, Carolyn Tyler and Heather Davidson discuss the immune system and neuroinflammation. …

You must be logged-in to view this content.

Log In

Foundations & Future Plans For Precision Medicine In The Treatment Of GAD

Generalized anxiety disorder (GAD) is a broad disorder marked by uncontrollable worry that affects daily life for at least six …

You must be logged-in to view this content.

Proposed Roles Of Modulating Norepinephrine In Psychiatric Illnesses

You must be logged-in to view this content.

Follow Up Q&A With Dr. Rowland – The Role Of Glutamate In Mood Disorders & Schizophrenia

You must be logged-in to view this content.

Follow Up Q&A With Dr. Murrough – The Role Of Glutamate In Mood Disorders & Schizophrenia

During this question and answer session, Dr. James Murrough responds to unanswered questions from the PsychU webinar, “The Role of …

You must be logged-in to view this content.

Cognitive Function & Neuroprotection In Schizophrenia

Schizophrenia has a worldwide prevalence of approximately 1%.1 Individuals living with the disease often experience neurocognitive deficits, as well as …

You must be logged-in to view this content.

The Neurobiology Of Endocannabinoids

You must be logged-in to view this content.

Revisiting Cognitive Deficits In Bipolar Disorder

Neurocognitive deficits are commonly experienced by individuals living with bipolar disorder. Bipolar disorder is known to affect attention, processing speed, …

You must be logged-in to view this content.

The Neurobiology Of Opioids

You must be logged-in to view this content.

The Role Of Glutamate In Mood Disorders & Schizophrenia

You must be logged-in to view this content.

Gender Differences In Depression

The prevalence of depressive disorders is higher in women than men. Why? Many factors are thought to contribute to the …

You must be logged-in to view this content.

Webinar Summary – Gender Differences In Depression

This summary was developed utilizing the full recorded presentation of this webinar. You can access the full sourcing, polling results, …

You must be logged-in to view this content.

Depression: From Molecule To Man

You must be logged-in to view this content.

Evolving Pharmacology Of Depression: Beyond The Monoamine Hypothesis

According to the World Health Organization, major depressive disorder (MDD) currently impacts 300 million individuals worldwide and is the leading …

You must be logged-in to view this content.

Webinar Summary – Evolving Psychopharmacology Of Depression: Beyond The Monoamine Hypothesis

You must be logged-in to view this content.

Can We Improve Functioning In Our Patients With Schizophrenia?

Clinicians are tasked daily with making informed decisions regarding patients. During this webinar, Greg Mattingly, MD, Medical Director at St. …

You must be logged-in to view this content.

Webinar Summary – Neuromodulation Techniques: State Of The Science

You must be logged-in to view this content.

Neuromodulation Techniques: State Of The Science

Clinicians managing patients with behavioral health issues are presented with various diagnostic and treatment challenges, spanning the areas of neurobiology, …

You must be logged-in to view this content.

Webinar Summary – The Evolution Of Post-Traumatic Stress Disorder: Focus On Diagnostic, Evaluation, & Treatment Advances

You must be logged-in to view this content.

The Evolution Of Post-Traumatic Stress Disorder: Focus On Diagnostic, Evaluation, & Treatment Advances

During this webinar William Sauvé, MD, Regional Medical Director at Greenbrook TMS Neurohealth in Glen Allen, Virginia and Steven Szabo, …

You must be logged-in to view this content.

Webinar Summary – The Interplay Between Sleep & Bipolar Disorder

You must be logged-in to view this content.

Webinar Summary – Update On The Role Of Gut Microbiota Modulation For The Treatment & Prevention Of Mood & Anxiety

You must be logged-in to view this content.

Update On The Role Of Gut Microbiota Modulation For The Treatment & Prevention Of Mood & Anxiety

In this webinar, experts Roger McIntyre, MD, FRCPC, Professor of Psychiatry & Pharmacology at the University of Toronto, Head of …

You must be logged-in to view this content.

Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, & Therapy

You must be logged-in to view this content.

The Relationship Between Genetic Risk Variants With Brain Structure & Function In Bipolar Disorder: A Systematic Review Of Genetic-Neuroimaging Studies

You must be logged-in to view this content.

Increasing Serum G72 Protein Levels In Patients With Schizophrenia: A Potential Candidate Biomarker

You must be logged-in to view this content.

Webinar Summary – The Power Of Mental Wellness: Wellness In Psychiatry

You must be logged-in to view this content.

The Power Of Mental Wellness: Wellness In Psychiatry

Data from a 30-day prescriptive wellness program supports the clinical repercussions of neglecting a targeted wellness strategy in the care …

You must be logged-in to view this content.

Treating The Synapse In Major Psychiatric Disorders: The Role of Postsynaptic Density Network In Dopamine-Glutamate Interplay & Psychopharmacologic Drugs Molecular Actions

You must be logged-in to view this content.

The Role Of DNA Methylation In The Pathophysiology & Treatment Of Bipolar Disorder

You must be logged-in to view this content.

Reduced Insulin-Receptor Mediated Modulation Of Striatal Dopamine Release By Basal Insulin As A Possible Contributing Factor To Hyperdomaminergia In Schizophrenia

You must be logged-in to view this content.

Genetic Variation & The D2 Dopamine Receptor: Implications For The Treatment Of Neuropsychiatric Disease

You must be logged-in to view this content.

Schizophrenia: The Role Of Sleep & Circadian Rhythms In Regulating Dopamine & Psychosis

You must be logged-in to view this content.

The Neurobiology Of Motivational Deficits In Depression – An Update On Candidate Pathomechanisms

You must be logged-in to view this content.

Clinical Application Of Psychopharmacology Of Schizophrenia – John Miller, MD

This interview with John Miller, MD is part 3 of the 3-part module series on Schizophrenia, from the Psychopharmacology Collection.

You must be logged-in to view this content.

Neurobiology Of Risk For Bipolar Disorder

You must be logged-in to view this content.

Neuroinflammation & White Matter Pathology In Schizophrenia: Systematic Review

You must be logged-in to view this content.

Neuroplasticity Underlying The Comorbidity Of Pain & Depression

You must be logged-in to view this content.

Neuroinflammation & Psychiatric Illness

You must be logged-in to view this content.

Dopamine Theory & Treatment Considerations In Schizophrenia

This video is part 1 in a series focusing on the psychopharmacology of schizophrenia. This video provides an overview of …

You must be logged-in to view this content.

Pathophysiology & Evolving Theories In Schizophrenia

This presentation is part 2 in a series focusing on the psychopharmacology of schizophrenia. This presentation reviews regions of the …

You must be logged-in to view this content.

Webinar Summary – Do Inflammation & Metabolic Disturbances Metastasize To The Brain? Implications For Disease Modeling & Novel Approaches In Psychiatry

You must be logged-in to view this content.

Theories Of Bipolar Disorder Pathophysiology

This video is part 2 of a series on Bipolar Disorder, from the Psychopharmacology Collection. This video briefly reviews some …

You must be logged-in to view this content.

miR-1202: A Primate-Specific & Brain-Enriched miRNA Involved In Major Depression & Antidepressant Treatment

You must be logged-in to view this content.

Webinar Summary – Future Of Psychopharmacology: Is New Treatment Innovation Still Alive?

This summary was developed utilizing the full recorded presentation of this virtual forum, which is available on PsychU for all …

You must be logged-in to view this content.

Follow Up Q&A – Treatment Of Schizophrenia: Focus On Psychopharmacology & Adherence

During this question and answer session, Henry A. Nasrallah, MD and Roger Sommi, PharmD, BCPP, FCCP respond to unanswered questions …

You must be logged-in to view this content.

Webinar Summary – Treatment Of Schizophrenia: Focus On Psychopharmacology & Adherence

This summary was developed utilizing the full recorded presentation of this webinar, which is available on PsychU for all members …

You must be logged-in to view this content.

Glial Abnormalities In Substance Use Disorders & Depression: Does Shared Glutamatergic Dysfunction Contribute To Comorbidity?

You must be logged-in to view this content.

Webinar Summary – Do Inflammation & Metabolic Disturbances Metastasize To The Brain? Implications For Disease Modeling & Novel Approaches In Psychiatry

You must be logged-in to view this content.

Do Inflammation & Metabolic Disturbances Metastasize To The Brain? Implications For Disease Modeling & Novel Approaches In Psychiatry (Inflammation Series Part 1)

During this webinar, Dr. Roger S. McIntyre, Professor of Psychiatry and Pharmacology (University of Toronto), Head of the Mood Disorders …

You must be logged-in to view this content.

Inflammation In Neurological & Psychiatric Diseases

You must be logged-in to view this content.

Inter-Relation Between Brain-Derived Neurotrophic Factor & Antioxidant Enzymes In Bipolar Disorder

You must be logged-in to view this content.

Depression, Serotonin & Tryptophan

You must be logged-in to view this content.

A Splitting Brain: Imbalanced Neural Networks In Schizophrenia

You must be logged-in to view this content.

The Comorbidity Of Insomnia, Chronic Pain, & Depression: Dopamine As A Putative Mechanism

You must be logged-in to view this content.

The Effects Of HPA Axis Function On Cognition & Its Implications For The Pathophysiology Of Bipolar Disorder

You must be logged-in to view this content.

Rethinking The Genetic Basis For Comorbidity Of Schizophrenia & Type 2 Diabetes

You must be logged-in to view this content.

The Overlap Between Anxiety, Depression, & Obsessive-Compulsive Disorder

You must be logged-in to view this content.

The Neurobiology Of Bipolar Disorder: Neuroimaging & Genetics Update

You must be logged-in to view this content.

Depression: From Psychopathology To Pathophysiology

You must be logged-in to view this content.

Cerebral Metabolism In Major Depressive Disorder: A Voxel-Based Meta-Analysis Of Positron Emission Tomography Studies

You must be logged-in to view this content.

The Potential Role Of Monocyte Chemoattractant Protein-1 For Major Depressive Disorder (MDD)

You must be logged-in to view this content.

Cognitive Dysfunction In Depression — Pathophysiology & Novel Targets

You must be logged-in to view this content.

Identifying Predictors, Moderators, & Mediators Of Antidepressant Response In Major Depressive Disorder: Neuroimaging Approaches

You must be logged-in to view this content.

Co-Occurring Psychotic & Addictive Disorders: Neurobiology & Diagnosis

You must be logged-in to view this content.

Major Depressive Disorder: Understanding The Significance Of Residual Symptoms & Balancing Efficacy With Tolerability

You must be logged-in to view this content.

The Role Of NMDA Receptors In The Pathophysiology & Treatment Of Mood Disorders

You must be logged-in to view this content.

Perspectives In Schizophrenia: Proposed Disease Pathophysiology & Potential Treatment Implications

During this recorded presentation, Robert E. Litman, MD, provided a brief overview of schizophrenia, the proposed disease pathophysiology, and implications …

You must be logged-in to view this content.

The Importance Of Norepinephrine In Depression

You must be logged-in to view this content.

Webinar Summary – Understanding The Role Of Neurotransmitters In The Treatment Of Depression

You must be logged-in to view this content.

Understanding The Role Of Neurotransmitters In The Treatment Of Depression

Major depressive disorder (MDD) is common, affecting an estimated 16 million US adults each year. However, less than 40% of …

You must be logged-in to view this content.

The Role Of Pro-inflammatory Cytokines In Neuroinflammation, Neurogenesis & The Neuroendocrine System In Major Depression

You must be logged-in to view this content.

The Neurobiology Of Relapse In Schizophrenia

You must be logged-in to view this content.

The Role Of Pro-Inflammatory Cytokines In The Neuroinflammation & Neurogenesis Of Schizophrenia

You must be logged-in to view this content.

Webinar Summary – The Evolving Psychopharmacology Of Major Depressive Disorder: Narrowing The Treatment Gap

You must be logged-in to view this content.

The Evolving Psychopharmacology Of Major Depressive Disorder: Narrowing The Treatment Gap

Depression is a widespread condition estimated to affect millions of adults in the United States alone. Despite the significant burden …

You must be logged-in to view this content.

Webinar Summary – Management Of Major Depressive Disorder (MDD): Breaking Through Barriers

You must be logged-in to view this content.

Management Of Major Depressive Disorder (MDD): Breaking Through The Barriers

An estimated 1 in 10 US adults report depression, with major depressive disorder (MDD) as common as diabetes or coronary …

You must be logged-in to view this content.

New Neuroimaging Research May Change The Way Mental Illness Is Diagnosed

You must be logged-in to view this content.

Schizophrenia Genetics: Emerging Themes For A Complex Disorder

You must be logged-in to view this content.

Webinar Summary – Does Relapse In Schizophrenia Cause Neurodegeneration? A Simulcast Debate & Webinar To Explore The Evidence

You must be logged-in to view this content.

Does Relapse In Schizophrenia Cause Neurodegeneration? A Simulcast Debate & Webinar To Explore The Evidence

There is a continuous debate in the mental health community around the progressive nature of schizophrenia as a disease: Is …

You must be logged-in to view this content.

Different & Shared Brain Volume Abnormalities In Late- & Early-Onset Schizophrenia

You must be logged-in to view this content.